Lederer & Associates Investment Counsel’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-6,283
Closed -$1.29M 89
2017
Q3
$1.29M Sell
6,283
-222
-3% -$51.6K 1.23% 38
2017
Q2
$1.58M Buy
6,505
+67
+1% +$15.7K 1.52% 30
2017
Q1
$1.54M Sell
6,438
-37
-0.6% -$8.62K 1.44% 35
2016
Q4
$1.36M Buy
+6,475
New +$1.34M 1.35% 39
2015
Q3
$1.89M Sell
6,948
-157
-2% -$48.2K 2.1% 15
2015
Q2
$2.16M Buy
7,105
+105
+2% +$31.3K 2.21% 11
2015
Q1
$2.08M Buy
+7,000
New +$2M 2.03% 12

Other funds holding AGN

Lederer & Associates Investment Counsel's AGN Position: Q4 2017 in Review

Lederer & Associates Investment Counsel sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 6,283 shares — an estimated $1.29M sold.

Lederer & Associates Investment Counsel first reported a position in AGN in Q1 2015 and held it in 7 quarters. The position peaked at $2.16M in Q2 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Lederer & Associates Investment Counsel reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Lederer & Associates Investment Counsel sold 6,283 Allergan plc shares in Q4 2017, an estimated $1.29M.
  • Lederer & Associates Investment Counsel first reported a position in Allergan plc in Q1 2015 and held it in 7 quarters.
  • Lederer & Associates Investment Counsel's Allergan plc position peaked at $2.16M in Q2 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Lederer & Associates Investment Counsel's 13F filing for Q4 2017, filed 11 Jan 2018.